- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Suraksha Diagnostic Ltd (SURK)
Track the Suraksha Diagnostic share price today and view real-time SURK share price data, including charts, technicals, and key financials. View the SURK premarket stock price ahead of the market session or assess the after hours quote. Explore SURK stock price movements, trading volume, and market activity across the NSE exchange.
What Is the Suraksha Diagnostic Stock Price Today?
The Suraksha Diagnostic stock price today is 332.45.
What Is the Stock Symbol for Suraksha Diagnostic?
The stock symbol for Suraksha Diagnostic is ""SURK.""
What Stock Exchange Does Suraksha Diagnostic Trade On?
Suraksha Diagnostic is listed and trades on the NSE stock exchange.
Is Suraksha Diagnostic a Good Stock to Buy?
Determining whether Suraksha Diagnostic or any stock is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the SURK quote. (ISIN: INE877V01027)
What Is the Suraksha Diagnostic Stock Price Today?
The Suraksha Diagnostic stock price today is 332.45.
What Is the Stock Symbol for Suraksha Diagnostic?
The stock symbol for Suraksha Diagnostic is ""SURK.""
What Stock Exchange Does Suraksha Diagnostic Trade On?
Suraksha Diagnostic is listed and trades on the NSE stock exchange.
Is Suraksha Diagnostic a Good Stock to Buy?
Determining whether Suraksha Diagnostic or any stock is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the SURK quote. (ISIN: INE877V01027)
332.45
-7.15(-2.11%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
331.00
340.70
52 wk Range
224.10
348.95
SURK is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
331.00340.70
52 wk Range
224.10348.95
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
SURK Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Neutral
Price Target
350.00
Upside
+5.28%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
RSI suggests the stock is in overbought territory
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell
Analyst Ratings
0 Buy
1 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Neutral
Analysts 12-Month Price Target:
Average 350.00
(+5.28% Upside)
Earnings
Latest Release
12/08/2026
EPS / Forecast
2.50 / --
Revenue / Forecast
876M / --
Compare SURK to Peers and Sector
Metrics to compare | SURK | Peers Peers - average of corresponding metrics from companies closely matching SURK: CHANDAN, METROPOLIS, VIJAYA, MAXHEALTH, AGARWALEYE | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipSURKPeersSector |
|---|---|---|---|---|
P/E Ratio | 48.6x | 55.7x | −0.4x | |
PEG Ratio | 5.10 | 0.84 | 0.00 | |
Price/Book | 7.1x | 6.5x | 2.6x | |
Price / LTM Sales | 5.3x | 3.4x | 3.1x | |
Upside (Analyst Target) | 5.1% | 16.5% | 49.6% | |
Fair Value Upside | Unlock | 2.7% | 7.1% | Unlock |
Suraksha Diagnostic Limited provides pathological and radiological services through diagnostic centers in India. It offers home collection services; pathology services, such as microbiology, serology, molecular biology, histopathology, cytopathology, clinical pathology, haematology, clinical biochemistry and immunology, immunohistochemistry, fluorescence in-situ hybridization, cytogenetics, flow cytometry, newborn screening, and NGS. The company also provides microarray, QF-PCR, FISH, karyotyping, and NIPT services; X-Ray, MRI scan, CT scan, USG, DEXA scan, Mammography, OPG radiology services; ECG, echocardiogram, stress test and treadmill test, wireless holter monitoring, and PFT cardiology services; EEG, EMG, and NCV neurology services; and upper GI and lower GI endoscopy, sigmoidoscopy, proctoscopy, colonoscopy, and proctosigmoidoscopy gastroenterology services. In addition, it offers clinic services, including dental, physiotherapy, immunology and rheumatology, ENT, eye, and specialty clinics, as well as fetal care; home doctor visit services; online doctor consultation; and doctor curated lab packages for bone and health, men’s and women’s health, senior citizens, diabetes care, fever, full-body checkups, and at-home packages. The company was founded in 1992 and is based in Kolkata, India.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Suraksha Diagnostic (SURK) Stock Price Today?
The Suraksha Diagnostic stock price today is 332.45 INR.
What Stock Exchange Does Suraksha Diagnostic Trade On?
Suraksha Diagnostic is listed and trades on the India National Stock Exchange.
What Is the Stock Symbol for Suraksha Diagnostic?
The stock symbol for Suraksha Diagnostic is "SURK."
What Is the Suraksha Diagnostic Market Cap?
As of today, Suraksha Diagnostic market cap is 17.69B INR.
What Is Suraksha Diagnostic's Earnings Per Share (TTM)?
The Suraksha Diagnostic EPS (TTM) is 6.88.
When Is the Next Suraksha Diagnostic Earnings Date?
Suraksha Diagnostic will release its next earnings report on 14/11/2026.
From a Technical Analysis Perspective, Is SURK a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Suraksha Diagnostic Stock Split?
Suraksha Diagnostic has split 0 times.
How Many Employees Does Suraksha Diagnostic Have?
Suraksha Diagnostic has 1600 employees.
What is the current trading status of Suraksha Diagnostic (SURK)?
As of 04/09/2026, Suraksha Diagnostic (SURK) is trading at a price of 332.45 INR, with a previous close of 339.60 INR. The stock has fluctuated within a day range of 331.00 INR to 340.70 INR, while its 52-week range spans from 224.10 INR to 348.95 INR.
What Is Suraksha Diagnostic (SURK) Price Target According to Analysts?
The average 12-month price target for Suraksha Diagnostic is 350.00 INR, with a high estimate of 350 INR and a low estimate of 350 INR. 0 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Neutral. The stock has an +5.28% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.